Share
Market Research Report

OPIOID USE DISORDER MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By Product TypeBuprenorphine (Oral, Parenteral, Others) · Naloxone (Parenteral and Others (Nasal Spray, etc.)) · Naltrexone (Oral and Parenteral) · Combination Drugs · and Methadone
  • By Route of AdministrationParenteral (Extended release Injection for Subcutaneous, Intramuscular) · Oral (Sublingual Tablet, Sublingual Film, Suspension) · and Others
  • By Dosage FormInjections · Sublingual film · Sublingual or Buccal · Tablet · Suspension · and Others
  • By AvailabilityPrescription and Over the Counter
  • By BrandSublocade · Suboxone · Brixadi · Vivitrol · Zubsolv · NARCAN · and Others
  • By Age GroupAdult and Children
  • By TypeBranded and Generic
  • By IndicationOpioid Addiction and Pain Management (Acute, Chronic)
  • By Distribution ChannelHospital Pharmacies · Retail Pharmacies · and Online Pharmacies
  • By GeographyNorth America · Europe · Asia Pacific · Latin America · Middle East · and Africa
  • Published In29 Apr 2026
  • Report CodeCMI4597
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033
  1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Drug Type
      • Market Snippet, By Route of Administration
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunities
    • Recent Test Launches
    • Product Launches/Approvals
    • Mergers, Acquisitions, and Collaborations
    • Regulatory Scenario
    • Key Developments
    • PEST Analysis
    • PORTER’s Analysis
  4. Global Opioid Use Disorder Market, By Drug Type,

    2021 - 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • Buprenorphine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
    • Methadone
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
    • Naltrexone
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
  5. Global Opioid Use Disorder Market, By Route of Administration,

    2021 - 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • Oral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
    • Parenteral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
  6. Global Opioid Use Disorder Market, By Distribution Channel, 2021 – 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • Hospitals Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
  7. Global Opioid Use Disorder Market, By Region, 2021 – 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021–2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021–2033, (US$ Bn)
        • U.S.
        • Canada
    • Latin America

      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth,  By Route of Administration, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021–2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021–2033, (US$ Bn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth,  By Drug Type, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth,  By Route of Administration, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021–2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021–2033, (US$ Bn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth,  By Drug Type, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth,  By Route of Administration, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021–2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021–2033, (US$ Bn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth,  By Drug Type, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth,  By Route of Administration, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021–2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021–2033, (US$ Bn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021–2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021–2033, (US$ Bn)
        • North Africa
        • Central Africa
        • South Africa
  8. Competitive Landscape

    • Company Profiles
      • Indivior PLC
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Alkermes
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Orexo AB
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Titan Pharmaceuticals, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Teva Pharmaceutical Industries Ltd.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Mallinckrodt Pharmaceuticals
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • BioDelivery Sciences International Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Viatris Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Hikma Pharmaceuticals PLC
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Camurus AB
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Sun Pharmaceutical Industries Ltd.
        •  Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Amneal Pharmaceuticals LLC.
        •  Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Purdue Pharma LP
        •  Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Alvogen
        •  Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Faran Shimi Pharmaceutical
        •  Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Novartis AG
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Emplicure AB
        •  Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • MODASA Pharmaceuticals Pvt. Ltd.
        •  Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
    • Analysts’ Views
  9. Section

    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 35 market data tables and 31 figures on “Global Opioid Use Disorder Market,” – Global forecast to 2033